Commission Implementing Decision (EU) 2015/1213 Article 3

Article 3

This Decision is addressed to Kaneka Pharma Europe NV Triomflaan 173, 1160 Brussels, Belgium.

Other provisions in Commission Implementing Decision (EU) 2015/1213

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 3 of Commission Implementing Decision (EU) 2015/1213 (LawPlayer, data as of 2026-07-04)

What to look at next

Commission Implementing Decision (EU) 2015/1213, full textThe complete text of this law, so you can read this section in contextEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview